{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:58:24Z","timestamp":1772236704499,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01390-2","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:00:03Z","timestamp":1769767203000},"page":"329-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-\u03b3\/IFN-\u03b2\/TGF-\u03b2 cocktail mRNA-LNP"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-2158","authenticated-orcid":false,"given":"Yabo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youli","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuying","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huafeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8476-1138","authenticated-orcid":false,"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"1390_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70:375\u2013403. https:\/\/doi.org\/10.3322\/caac.21626.","journal-title":"CA Cancer J Clin"},{"key":"1390_CR2","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH. Challenges and Opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 2020;38:788\u2013802. https:\/\/doi.org\/10.1016\/j.ccell.2020.08.004.","journal-title":"Cancer Cell"},{"key":"1390_CR3","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/s1470-2045(19)30795-8","volume":"21","author":"ES Christenson","year":"2020","unstructured":"Christenson ES, Jaffee E, Azad NS. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Lancet Oncol. 2020;21:e135\u2013e45. https:\/\/doi.org\/10.1016\/s1470-2045(19)30795-8.","journal-title":"Lancet Oncol"},{"key":"1390_CR4","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1158\/1078-0432.Ccr-06-2351","volume":"13","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res. 2007;13:2870\u20135. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-2351.","journal-title":"Clin Cancer Res"},{"key":"1390_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s1470-2045(04)01606-7","volume":"5","author":"AA Khorana","year":"2004","unstructured":"Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol. 2004;5:655\u201363. https:\/\/doi.org\/10.1016\/s1470-2045(04)01606-7.","journal-title":"Lancet Oncol"},{"key":"1390_CR6","doi-asserted-by":"publisher","unstructured":"Risman RA, Milman N, Sinan H, Tutwiler V. Clot formation, structure, and fibrinolysis of pancreatic cancer patients. Res Sq. 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-5868575\/v1.","DOI":"10.21203\/rs.3.rs-5868575\/v1"},{"key":"1390_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115027","volume":"200","author":"R Wahab","year":"2023","unstructured":"Wahab R, Hasan MM, Azam Z, Grippo PJ, Al-Hilal TA. The role of coagulome in the tumor immune microenvironment. Adv Drug Deliv Rev. 2023;200:115027. https:\/\/doi.org\/10.1016\/j.addr.2023.115027.","journal-title":"Adv Drug Deliv Rev"},{"key":"1390_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1053\/j.gastro.2019.12.009","volume":"158","author":"C Frere","year":"2020","unstructured":"Frere C, Bournet B, Gourgou S, Fraisse J, Canivet C, Connors JM, et al. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. Gastroenterology. 2020;158:1346\u201358.e4. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.009.","journal-title":"Gastroenterology"},{"key":"1390_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq6024","volume":"15","author":"J Lv","year":"2023","unstructured":"Lv J, Zhou Y, Zhou N, Wang Z, Chen J, Chen H, et al. Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells. Sci Transl Med. 2023;15:eabq6024. https:\/\/doi.org\/10.1126\/scitranslmed.abq6024.","journal-title":"Sci Transl Med"},{"key":"1390_CR10","doi-asserted-by":"publisher","DOI":"10.34133\/research.0215","volume":"6","author":"J Lv","year":"2023","unstructured":"Lv J, Liu X, Zhou Y, Cheng F, Chen H, Li S, et al. YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation. Res (Wash D C). 2023;6:0215. https:\/\/doi.org\/10.34133\/research.0215.","journal-title":"Res (Wash D C)"},{"key":"1390_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liang X, Dong W, Fang Y, Lv J, Zhang T, et al. Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation. Cancer Cell. 2018;33:480\u201394.e7. https:\/\/doi.org\/10.1016\/j.ccell.2018.02.005.","journal-title":"Cancer Cell"},{"key":"1390_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nmat3361","volume":"11","author":"J Liu","year":"2012","unstructured":"Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, et al. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater. 2012;11:734\u201341. https:\/\/doi.org\/10.1038\/nmat3361.","journal-title":"Nat Mater"},{"key":"1390_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/0008-5472.Can-20-2569","volume":"81","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang T, Zhang H, Li J, Zhou N, Fiskesund R, et al. Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells. Cancer Res. 2021;81:476\u201388. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2569.","journal-title":"Cancer Res"},{"key":"1390_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/cr.2016.53","volume":"26","author":"J Ma","year":"2016","unstructured":"Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, et al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res. 2016;26:713\u201327. https:\/\/doi.org\/10.1038\/cr.2016.53.","journal-title":"Cell Res"},{"key":"1390_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41556-022-00857-4","volume":"24","author":"J Lv","year":"2022","unstructured":"Lv J, Liu Y, Mo S, Zhou Y, Chen F, Cheng F, et al. Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. Nat Cell Biol. 2022;24:364\u201372. https:\/\/doi.org\/10.1038\/s41556-022-00857-4.","journal-title":"Nat Cell Biol"},{"key":"1390_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","volume":"18","author":"EC Borden","year":"2019","unstructured":"Borden EC. Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov. 2019;18:219\u201334. https:\/\/doi.org\/10.1038\/s41573-018-0011-2.","journal-title":"Nat Rev Drug Discov"},{"key":"1390_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFN\u03b3: signaling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18:545\u201358. https:\/\/doi.org\/10.1038\/s41577-018-0029-z.","journal-title":"Nat Rev Immunol"},{"key":"1390_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15207","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liang X, Yin X, Lv J, Tang K, Ma J, et al. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-\u03b3-induced immunologic dormancy of tumor-repopulating cells. Nat Commun. 2017;8:15207. https:\/\/doi.org\/10.1038\/ncomms15207.","journal-title":"Nat Commun"},{"key":"1390_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1172\/jci96329","volume":"128","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lv J, Liu J, Liang X, Jin X, Xie J, et al. STAT3\/p53 pathway activation disrupts IFN-\u03b2-induced dormancy in tumor-repopulating cells. J Clin Invest. 2018;128:1057\u201373. https:\/\/doi.org\/10.1172\/jci96329.","journal-title":"J Clin Invest"},{"key":"1390_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier C, Baker D, Ten Dijke P, Ritsma L. TGF-\u03b2 Family Signaling Pathways in Cellular Dormancy. Trends Cancer. 2019;5:66\u201378. https:\/\/doi.org\/10.1016\/j.trecan.2018.10.010.","journal-title":"Trends Cancer"},{"key":"1390_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"1390_CR22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41556-024-01474-z","volume":"26","author":"KW Chen","year":"2024","unstructured":"Chen KW, Broz P. Gasdermins as evolutionarily conserved executors of inflammation and cell death. Nat Cell Biol. 2024;26:1394\u2013406. https:\/\/doi.org\/10.1038\/s41556-024-01474-z.","journal-title":"Nat Cell Biol"},{"key":"1390_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20:143\u201357. https:\/\/doi.org\/10.1038\/s41577-019-0228-2.","journal-title":"Nat Rev Immunol"},{"key":"1390_CR24","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.immuni.2023.10.004","volume":"56","author":"R Miao","year":"2023","unstructured":"Miao R, Jiang C, Chang WY, Zhang H, An J, Ho F, et al. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity. 2023;56:2523\u201341.e8. https:\/\/doi.org\/10.1016\/j.immuni.2023.10.004.","journal-title":"Immunity"},{"key":"1390_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41423-018-0165-1","volume":"16","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zhang T, Zhou Y, Li J, Liang X, Zhou N, et al. Visualization of perforin\/gasdermin\/complement-formed pores in real cell membranes using atomic force microscopy. Cell Mol Immunol. 2019;16:611\u201320. https:\/\/doi.org\/10.1038\/s41423-018-0165-1.","journal-title":"Cell Mol Immunol"},{"key":"1390_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103. https:\/\/doi.org\/10.1038\/nature22393.","journal-title":"Nature"},{"key":"1390_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jhep.2021.06.031","volume":"75","author":"P Ruiz-Bl\u00e1zquez","year":"2021","unstructured":"Ruiz-Bl\u00e1zquez P, Pistorio V, Fern\u00e1ndez-Fern\u00e1ndez M, Moles A. The multifaceted role of cathepsins in liver disease. J Hepatol. 2021;75:1192\u2013202. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.031.","journal-title":"J Hepatol"},{"key":"1390_CR28","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41556-024-01503-x","volume":"26","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liu J, Yuan W, Zhang Q, Luo X, Li Y, et al. Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8(+) T cells. Nat Cell Biol. 2024;26:1892\u2013902. https:\/\/doi.org\/10.1038\/s41556-024-01503-x.","journal-title":"Nat Cell Biol"},{"key":"1390_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121609119","volume":"119","author":"RT Vest","year":"2022","unstructured":"Vest RT, Chou CC, Zhang H, Haney MS, Li L, Laqtom NN, et al. Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration. Proc Natl Acad Sci USA. 2022;119:e2121609119. https:\/\/doi.org\/10.1073\/pnas.2121609119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1390_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cell.2020.03.031","volume":"181","author":"M Zhang","year":"2020","unstructured":"Zhang M, Liu L, Lin X, Wang Y, Li Y, Guo Q, et al. A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion. Cell. 2020;181:637\u201352.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.03.031.","journal-title":"Cell"},{"key":"1390_CR31","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1080\/15548627.2015.1063871","volume":"11","author":"S Aits","year":"2015","unstructured":"Aits S, Kricker J, Liu B, Ellegaard AM, H\u00e4m\u00e4list\u00f6 S, Tvingsholm S, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy. 2015;11:1408\u201324. https:\/\/doi.org\/10.1080\/15548627.2015.1063871.","journal-title":"Autophagy"},{"key":"1390_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41586-022-05164-4","volume":"609","author":"JX Tan","year":"2022","unstructured":"Tan JX, Finkel T. A phosphoinositide signaling pathway mediates rapid lysosomal repair. Nature. 2022;609:815\u201321. https:\/\/doi.org\/10.1038\/s41586-022-05164-4.","journal-title":"Nature"},{"key":"1390_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10:1689. https:\/\/doi.org\/10.1038\/s41467-019-09397-2.","journal-title":"Nat Commun"},{"key":"1390_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41590-023-01738-0","volume":"25","author":"J Ma","year":"2024","unstructured":"Ma J, Tang L, Tan Y, Xiao J, Wei K, Zhang X, et al. Lithium carbonate revitalizes tumor-reactive CD8(+) T cells by shunting lactic acid into mitochondria. Nat Immunol. 2024;25:552\u201361. https:\/\/doi.org\/10.1038\/s41590-023-01738-0.","journal-title":"Nat Immunol"},{"key":"1390_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat Rev Immunol. 2005;5:375\u201386. https:\/\/doi.org\/10.1038\/nri1604.","journal-title":"Nat Rev Immunol"},{"key":"1390_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4049\/jimmunol.1102041","volume":"189","author":"T Matsuzawa","year":"2012","unstructured":"Matsuzawa T, Kim BH, Shenoy AR, Kamitani S, Miyake M, Macmicking JD. IFN-\u03b3 elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol. 2012;189:813\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1102041.","journal-title":"J Immunol"},{"key":"1390_CR37","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","volume":"155","author":"B Chen","year":"2013","unstructured":"Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system. Cell. 2013;155:1479\u201391. https:\/\/doi.org\/10.1016\/j.cell.2013.12.001.","journal-title":"Cell"},{"key":"1390_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tibs.2010.03.002","volume":"35","author":"M Bollen","year":"2010","unstructured":"Bollen M, Peti W, Ragusa MJ, Beullens M. The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci. 2010;35:450\u20138. https:\/\/doi.org\/10.1016\/j.tibs.2010.03.002.","journal-title":"Trends Biochem Sci"},{"key":"1390_CR39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cmet.2017.03.011","volume":"25","author":"L Calvier","year":"2017","unstructured":"Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, et al. PPAR\u03b3 Links BMP2 and TGF\u03b21 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism. Cell Metab. 2017;25:1118\u201334.e7. https:\/\/doi.org\/10.1016\/j.cmet.2017.03.011.","journal-title":"Cell Metab"},{"key":"1390_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","volume":"22","author":"RA Saxton","year":"2023","unstructured":"Saxton RA, Glassman CR, Garcia KC. Emerging principles of cytokine pharmacology and therapeutics. Nat Rev Drug Discov. 2023;22:21\u201337. https:\/\/doi.org\/10.1038\/s41573-022-00557-6.","journal-title":"Nat Rev Drug Discov"},{"key":"1390_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon E, Ad-El N, Hazan-Halevy I, Stotsky-Oterin L, Peer D. Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects. Nat Rev Clin Oncol. 2023;20:739\u201354. https:\/\/doi.org\/10.1038\/s41571-023-00811-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"1390_CR42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078\u201394. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"key":"1390_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9 J. TGFbeta in Cancer. Cell. 2008;134:215\u201330. https:\/\/doi.org\/10.1016\/j.cell.2008.07.001.","journal-title":"Cell"},{"key":"1390_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19:237\u201353. https:\/\/doi.org\/10.1038\/s41571-021-00588-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"1390_CR45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s43018-023-00668-y","volume":"5","author":"A Ghasemi","year":"2024","unstructured":"Ghasemi A, Martinez-Usatorre A, Li L, Hicham M, Guichard A, Marcone R, et al. Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Nat Cancer. 2024;5:240\u201361. https:\/\/doi.org\/10.1038\/s43018-023-00668-y.","journal-title":"Nat Cancer"},{"key":"1390_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","volume":"36","author":"K Adachi","year":"2018","unstructured":"Adachi K, Kano Y, Nagai T, Okuyama N, Sakoda Y, Tamada K. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T-cell survival in the tumor. Nat Biotechnol. 2018;36:346\u201351. https:\/\/doi.org\/10.1038\/nbt.4086.","journal-title":"Nat Biotechnol"},{"key":"1390_CR47","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41587-023-02060-8","volume":"42","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen J, Andreatta M, Feng B, Xie YQ, Wenes M, et al. IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nat Biotechnol. 2024;42:1693\u2013704. https:\/\/doi.org\/10.1038\/s41587-023-02060-8.","journal-title":"Nat Biotechnol"},{"key":"1390_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1349-7006.2006.00351.x","volume":"98","author":"K Akino","year":"2007","unstructured":"Akino K, Toyota M, Suzuki H, Imai T, Maruyama R, Kusano M, et al. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer. Cancer Sci. 2007;98:88\u201395. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00351.x.","journal-title":"Cancer Sci"},{"key":"1390_CR49","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/sj.onc.1211021","volume":"27","author":"MS Kim","year":"2008","unstructured":"Kim MS, Chang X, Yamashita K, Nagpal JK, Baek JH, Wu G, et al. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 2008;27:3624\u201334. https:\/\/doi.org\/10.1038\/sj.onc.1211021.","journal-title":"Oncogene"},{"key":"1390_CR50","doi-asserted-by":"publisher","unstructured":"Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020;5. https:\/\/doi.org\/10.1126\/sciimmunol.aax7969.","DOI":"10.1126\/sciimmunol.aax7969"},{"key":"1390_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","volume":"55","author":"E Duong","year":"2022","unstructured":"Duong E, Fessenden TB, Lutz E, Dinter T, Yim L, Blatt S, et al. Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity. Immunity. 2022;55:308\u201323.e9. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.020.","journal-title":"Immunity"},{"key":"1390_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","volume":"135","author":"PM George","year":"2012","unstructured":"George PM, Badiger R, Alazawi W, Foster GR, Mitchell JA. Pharmacology and therapeutic potential of interferons. Pharm Ther. 2012;135:44\u201353. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.006.","journal-title":"Pharm Ther"},{"key":"1390_CR53","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.cell.2022.06.038","volume":"185","author":"CG Weindel","year":"2022","unstructured":"Weindel CG, Martinez EL, Zhao X, Mabry CJ, Bell SL, Vail KJ, et al. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell. 2022;185:3214\u201331.e23. https:\/\/doi.org\/10.1016\/j.cell.2022.06.038.","journal-title":"Cell"},{"key":"1390_CR54","doi-asserted-by":"publisher","unstructured":"Lloyd-Evans E, Waller-Evans H. Lysosomal Ca(2+) Homeostasis and Signaling in Health and Disease. Cold Spring Harb Perspect Biol. 2020;12. https:\/\/doi.org\/10.1101\/cshperspect.a035311.","DOI":"10.1101\/cshperspect.a035311"},{"key":"1390_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2023.102751","volume":"113","author":"M Milani","year":"2023","unstructured":"Milani M, Pih\u00e1n P, Hetz C. Calcium signaling in lysosome-dependent cell death. Cell Calcium. 2023;113:102751. https:\/\/doi.org\/10.1016\/j.ceca.2023.102751.","journal-title":"Cell Calcium"},{"key":"1390_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/bst20170130","volume":"46","author":"A Serrano-Puebla","year":"2018","unstructured":"Serrano-Puebla A, Boya P. Lysosomal membrane permeabilization as a cell death mechanism in cancer cells. Biochem Soc Trans. 2018;46:207\u201315. https:\/\/doi.org\/10.1042\/bst20170130.","journal-title":"Biochem Soc Trans"},{"key":"1390_CR57","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumor microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527\u201340. https:\/\/doi.org\/10.1038\/s41571-020-0363-5.","journal-title":"Nat Rev Clin Oncol"},{"key":"1390_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbpa.2021.01.007","volume":"62","author":"L Bonati","year":"2021","unstructured":"Bonati L, Tang L. Cytokine engineering for targeted cancer immunotherapy. Curr Opin Chem Biol. 2021;62:43\u201352. https:\/\/doi.org\/10.1016\/j.cbpa.2021.01.007.","journal-title":"Curr Opin Chem Biol"},{"key":"1390_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumors with combination immunotherapies. Nat Rev Drug Discov. 2019;18:197\u2013218. https:\/\/doi.org\/10.1038\/s41573-018-0007-y.","journal-title":"Nat Rev Drug Discov"},{"key":"1390_CR60","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov. 2024;23:445\u201360. https:\/\/doi.org\/10.1038\/s41573-024-00920-9.","journal-title":"Nat Rev Drug Discov"},{"key":"1390_CR61","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.gendis.2022.10.019","volume":"10","author":"Q Luo","year":"2023","unstructured":"Luo Q, Hu Z, Zhao H, Fan Y, Tu X, Wang Y, et al. The role of TGF-\u03b2 in the tumor microenvironment of pancreatic cancer. Genes Dis. 2023;10:1513\u201324. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.019.","journal-title":"Genes Dis"},{"key":"1390_CR62","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s43018-023-00570-7","volume":"4","author":"M Boulch","year":"2023","unstructured":"Boulch M, Cazaux M, Cuffel A, Guerin MV, Garcia Z, Alonso R, et al. Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-\u03b3 is a major determinant of CD4(+) CAR T-cell antitumor activity. Nat Cancer. 2023;4:968\u201383. https:\/\/doi.org\/10.1038\/s43018-023-00570-7.","journal-title":"Nat Cancer"},{"key":"1390_CR63","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024;5:572\u201389. https:\/\/doi.org\/10.1038\/s43018-023-00715-8.","journal-title":"Nat Cancer"},{"key":"1390_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10431","volume":"7","author":"K Yoshimi","year":"2016","unstructured":"Yoshimi K, Kunihiro Y, Kaneko T, Nagahora H, Voigt B, Mashimo T. ssODN-mediated knock-in with CRISPR\u2012Cas for large genomic regions in zygotes. Nat Commun. 2016;7:10431. https:\/\/doi.org\/10.1038\/ncomms10431.","journal-title":"Nat Commun"},{"key":"1390_CR65","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","volume":"291","author":"H Parhiz","year":"2018","unstructured":"Parhiz H, Shuvaev VV, Pardi N, Khoshnejad M, Kiseleva RY, Brenner JS, et al. PECAM-1 directed retargeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. J Control Release. 2018;291:106\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.015.","journal-title":"J Control Release"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01390-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01390-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01390-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:02:41Z","timestamp":1772233361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01390-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01390-2","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare that they have no competing interests. B.H. is an editorial board member of Cellular & Molecular Immunology, but he has not been involved in the peer review or the decision-making of the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}